Kim Hyunho, Kim Eunyoung, Lee Ingoo, Bae Bongsung, Park Minsu, Nam Hojung
School of Electrical Engineering and Computer Science, Gwangju Institute of Science and Technology (GIST), Gwangju, 61005 Korea.
Biotechnol Bioprocess Eng. 2020;25(6):895-930. doi: 10.1007/s12257-020-0049-y. Epub 2021 Jan 7.
As expenditure on drug development increases exponentially, the overall drug discovery process requires a sustainable revolution. Since artificial intelligence (AI) is leading the fourth industrial revolution, AI can be considered as a viable solution for unstable drug research and development. Generally, AI is applied to fields with sufficient data such as computer vision and natural language processing, but there are many efforts to revolutionize the existing drug discovery process by applying AI. This review provides a comprehensive, organized summary of the recent research trends in AI-guided drug discovery process including target identification, hit identification, ADMET prediction, lead optimization, and drug repositioning. The main data sources in each field are also summarized in this review. In addition, an in-depth analysis of the remaining challenges and limitations will be provided, and proposals for promising future directions in each of the aforementioned areas.
随着药物研发支出呈指数级增长,整个药物发现过程需要一场可持续的变革。由于人工智能(AI)引领着第四次工业革命,因此可将其视为解决不稳定的药物研发问题的可行方案。一般来说,AI应用于具有足够数据的领域,如计算机视觉和自然语言处理,但也有许多通过应用AI来革新现有药物发现过程的努力。本综述全面、系统地总结了AI引导的药物发现过程中包括靶点识别、活性分子识别、药物代谢及药物安全性预测(ADMET)、先导化合物优化和药物重新定位等方面的最新研究趋势。每个领域的主要数据源也在本综述中进行了总结。此外,还将对剩余的挑战和局限性进行深入分析,并针对上述每个领域提出有前景的未来发展方向建议。